.png)
Select your peptide format (pool, library, microarray...), peptide purity (from crude up to >95%) and optional modifications (phosphorylation, biotin, dyes and labeled, cyclization, conjugation, stable-isotope labeling, etc.).
Our product range includes micro-scale synthesis (10-50 nmol), intermediate peptide synthesis (1-100 mg), and large-scale peptide synthesis (>1 g).
Over the last 20 years, we have developed a unique and very broad expertise in peptide manufacturing and have pioneered patented technologies in the field of peptide libraries, pools and microarrays as well as micro-scale synthesis.
Our Quality Management
Since 2004, JPT has maintained an active quality management system that is reviewed, audited, and certified annually by an independent certification body (TÜV Rheinland) to ISO 9001:2015 standards.
Product Finder
Research Fields
.jpg "PepMix™ Influenza A (HA/H5N8/Astrakhan/2020)")
.jpg "PepMix™ Influenza A (HA/H7N9/2016-17)")
Supporting Clinical Trials! - Trial Grade Peptide Libraries
The transition from discovery research to clinical development is one of the most critical phases in medicinal research. Data generated in early screening and target discovery must now be translated into robust, reproducible, and regulatory-compliant tools suitable for clinical studies. JPT’s Trial Grade and Premium Grade peptide libraries will support your clinical research!
(Macro-)Cyclic Libraries in Drug Discovery & Optimization
As drug discovery increasingly targets complex and previously ‘untargetable’ protein interfaces, researchers require molecular formats that combine high binding specificity, structural stability, but also flexible pharmacological properties. (Macro-)cyclic peptides meet these requirements!
Advancing Epitope Discovery, Target Identification & Immune Monitoring
Next in this series: we will dive into the more immunological aspect. Understanding how the immune system recognizes antigens is central to modern medicinal research. Whether developing vaccines, characterizing T cell immune responses to infection, or discovering tumor-specific neo-epitopes in oncology, researchers rely on precise tools.